The Cancer Prevention & Research Institute of Texas is seeking applications for its Texas New Technologies Company Awards.
Donor Name: Cancer Prevention & Research Institute of Texas
State: Texas
County: All Counties
Type of Grant: Grant
Deadline: 06/30/2023
Grant Duration: 36 months
Details:
CPRIT’s Product Development Research Program Priorities
In addition to overarching principles that include scientific excellence, impact on cancer, and increasing the state’s life science infrastructure, CPRIT’s Oversight Committee establishes annual priorities for each of its 3 programs. The priorities guide CPRIT in the development of RFAs and the evaluation of applications considered for awards.
The Product Development Research Program’s priorities for FY 2024 are as follows:
- Funding novel projects that offer therapeutic or diagnostic benefits; ie, disruptive technologies
- Funding projects addressing large or challenging unmet medical needs
- Investing in early-stage projects when private capital is least available
- Stimulating commercialization of technologies developed at Texas entities
- Supporting new company formation in Texas or attracting promising companies to Texasthat will recruit staff with life science expertise, especially experienced C-level staff
- Providing appropriate return on Texas taxpayer investment.
Funding Stage for Texas New Technologies Company Awards
Funding available through this RFA supports the ongoing research and development of new and emerging technologies for the detection, diagnosis, prognosis, monitoring, or treatment of cancer. CPRIT created this RFA to fund new and emerging technology projects that do not easily fit into any of the three other CPRIT Product Development Research RFAs. Proposals may include, but are not limited to, bioinformatics, artificial intelligence, production of radionuclides or their precursors, manufacture of cell-based therapies, processes to improve the quality of the samples used for cancer research or clinical care, and bio-manufacturing of therapeutics.
With appropriate justification, companies may use CPRIT funds to support studies that establish preclinical proof of concept, product validation, design, production, manufacturing and development, and clinical studies demonstrating safety and efficacy.
Grant Period
Maximum of 36 months.
Allowable Expenses
Companies may use CPRIT funds for expenses associated only with activities directly related to the specific project that CPRIT is funding. Allowable expenses include the following:
- Salary and fringe benefits
- Research supplies
- Equipment
- Clinical trial expenses
- Intellectual property (IP) acquisition and protection
- External consultants and service providers
- Travel in support of the project
- Other appropriate research and development costs, subject to certain limitations set forth by Texas law.
Eligibility Criteria
CPRIT considers a company to be Texas-based if it fulfills at least 4 of the following criteria:
- The US headquarters are physically located in Texas
- The chief executive officer resides in Texas
- A majority of the company’s personnel, including at least 2 other C-level employees (or equivalent), reside in Texas
- Manufacturing activities take place in Texas
- At least 90% of grant award funds are paid to individuals and entities in Texas, including salaries and personnel costs for employees and contractors
- At least 1 clinical trial site is in Texas
- The company collaborates with a medical research organization in Texas, including a public or private institution of higher education.
For more information, visit CPRIT.
